Sermorelin vs Ipamorelin vs CJC-1295: Three-Way Comparison for Anti-Aging, Bodybuilding & Sleep

Three growth hormone peptides dominate the conversation in anti-aging clinics, performance circles, and biohacker communities: Sermorelin, Ipamorelin, and CJC-1295. All three increase growth hormone (GH) output, but they do so through different mechanisms, produce different GH pulse profiles, and serve different goals better than the others. This three-way comparison breaks down exactly how they work, where each one excels, and how to choose the right protocol.

The Growth Hormone Axis: Why Mechanism Matters

Before comparing compounds, it helps to understand what each one is actually doing at a receptor level.

Growth hormone secretion is governed by two competing signals from the hypothalamus: growth hormone-releasing hormone (GHRH) stimulates GH release, while somatostatin inhibits it. The pituitary also responds to ghrelin through the growth hormone secretagogue receptor (GHS-R).

• Sermorelin and CJC-1295 are both GHRH analogs — they mimic the body's natural GHRH signal at the pituitary
• Ipamorelin is a GH secretagogue (GHRP class) — it acts on GHS-R, the ghrelin receptor, to trigger GH release through an entirely separate pathway

This distinction matters enormously for pulse characteristics, hormonal side effects, and synergy when combining peptides.

Sermorelin: The Original GHRH Analog

Sermorelin is a synthetic analog of the first 29 amino acids of natural GHRH (which has 44 amino acids). It was FDA-approved in 1997 for treating growth hormone deficiency in children and later used off-label for adult anti-aging indications before its commercial production was discontinued (it remains available from compounding pharmacies).

How it works: Sermorelin binds pituitary GHRH receptors and stimulates GH release in a manner that preserves physiologic feedback. Critically, it respects the somatostatin brake — if somatostatin is high (as it is during the day), sermorelin's effect is blunted. This is why sermorelin is typically dosed at night, timed with the natural GH pulse.

Half-life: Approximately 10–20 minutes. Short half-life means it produces one clean GH pulse per injection.

Typical dose: 200–500 mcg subcutaneous injection before bed.

Full protocol details in the Sermorelin guide.

Ipamorelin: The Clean GHRP

Ipamorelin is a third-generation GHRP — a selective GH secretagogue that acts on the ghrelin receptor. It is considered the "cleanest" GHRP because it stimulates GH release without the prolactin or cortisol spikes seen with older secretagogues like GHRP-2 or GHRP-6.

How it works: Ipamorelin activates GHS-R on pituitary somatotrophs to trigger GH release. It also suppresses somatostatin briefly, which amplifies the GH pulse. This dual action makes it highly effective at producing strong, clean GH pulses.

Half-life: Approximately 2 hours. Slightly longer than Sermorelin but still relatively short.

Typical dose: 200–300 mcg subcutaneous injection, 1–3x daily or before bed.

Unique advantage: Ipamorelin does not increase appetite (unlike GHRP-6), does not raise cortisol (unlike GHRP-2), and does not desensitize receptors at typical doses. It is the GHRP of choice for most clinical protocols.

See the Ipamorelin peptide guide for more.

CJC-1295: The Long-Acting GHRH Analog

CJC-1295 is a GHRH analog engineered for extended activity. There are two forms that cause significant confusion:

• CJC-1295 with DAC (Drug Affinity Complex): Half-life of 6–8 days. Binds to albumin in plasma for sustained release. Produces a continuous "GH bleed" rather than pulsatile release. Dosed once or twice per week.
• CJC-1295 without DAC (also called Mod GRF 1-29): Half-life of ~30 minutes. Produces a sharp, pulsatile GH release similar to Sermorelin but with greater potency.

The vast majority of peptide protocols that say "CJC-1295" are referring to CJC-1295 without DAC (Mod GRF 1-29), combined with Ipamorelin. The DAC version has fallen out of favor in most anti-aging contexts because continuous GH elevation suppresses natural pulsatility and may increase IGF-1 beyond optimal ranges.

Typical dose (without DAC): 100–300 mcg per injection, combined with Ipamorelin.

Head-to-Head Comparison

| Feature | Sermorelin | Ipamorelin | CJC-1295 (no DAC) | |---|---|---|---| | Mechanism | GHRH analog | GHRP/ghrelin agonist | GHRH analog | | Half-life | 10–20 min | ~2 hours | ~30 min | | GH pulse quality | Physiologic, moderate | Strong, clean | Strong, pulsatile | | Cortisol effect | None | None | None | | Prolactin effect | None | None | None | | FDA status | Compounding only | Research peptide | Research peptide | | Best for | Anti-aging, beginners | All-purpose, stacking | Stacking with Ipamorelin | | Monotherapy effectiveness | Moderate | Moderate | Moderate | | Cost | Moderate | Low-moderate | Low-moderate |

Which Is Best for Anti-Aging?

For anti-aging goals — improved skin quality, body composition, energy, and sleep — Sermorelin has the longest clinical track record given its FDA-approval history. However, the CJC-1295 + Ipamorelin combination is now the standard of care in most functional medicine and anti-aging clinics because it produces larger, cleaner GH pulses than either GHRH analog or GHRP alone.

The reason this combination is so effective: GHRH analogs and GHRPs act on completely different receptors and synergize multiplicatively — together they produce 4–10x the GH release of either compound alone in animal studies. This is not additive; it is synergistic.

Recommended anti-aging protocol:

• CJC-1295 (no DAC) 200 mcg + Ipamorelin 200 mcg subcutaneous injection before bed
• 5 days on, 2 days off cycling
• 3–6 month courses

Which Is Best for Bodybuilding and Fat Loss?

For performance and body composition, higher GH pulse amplitude matters. The CJC-1295 + Ipamorelin combination again leads, with some protocols adding a second injection 30 minutes before training or first thing in the morning on an empty stomach.

Sermorelin alone is generally insufficient for notable body composition changes in healthy adults — its GH pulses are too modest relative to what the combination produces.

For pure fat loss, some protocols add Tesamorelin — a more potent GHRH analog with specific visceral fat-loss data — or incorporate AOD-9604 for targeted lipolysis.

Which Is Best for Sleep?

All three improve sleep quality through GH's role in slow-wave sleep architecture. However, Sermorelin has the most direct clinical data on sleep improvement, partly because most of its trials used nighttime dosing that naturally synchronized with the deep sleep GH pulse.

For sleep specifically, timing matters more than compound choice. Any of these three, dosed 30–60 minutes before bed on an empty stomach, will amplify the natural GH surge that occurs during the first deep sleep cycle. Combining this with DSIP (Delta Sleep-Inducing Peptide) can further enhance sleep architecture.

Sermorelin Alone vs CJC-1295/Ipamorelin Stack

The practical question most people face: start with Sermorelin monotherapy or go straight to the combination?

Case for Sermorelin monotherapy:

• Lowest cost entry point
• Well-understood safety profile
• Good for individuals new to GH peptide therapy
• Appropriate for very conservative protocols (elderly patients, those with cardiovascular history)

Case for CJC-1295 + Ipamorelin combination:

• Significantly more effective at raising GH and IGF-1
• Single injection covers both receptor pathways
• Standard in most reputable peptide clinics
• Better evidence base for body composition outcomes

Most users who start with Sermorelin eventually transition to the combination. If cost and access allow, starting with CJC-1295/Ipamorelin is more efficient.

Side Effects Comparison

All three are generally well tolerated. Common side effects across all GH-stimulating peptides:

• Transient water retention (first 2–4 weeks)
• Mild tingling in hands/feet (carpal tunnel-like, dose-dependent)
• Flushing or facial warmth at higher doses
• Morning fatigue if dosed too late

Ipamorelin specifically avoids the hunger, cortisol, and prolactin issues associated with older GHRPs. CJC-1295 without DAC avoids the continuous IGF-1 elevation concern of the DAC version. Sermorelin is considered the most conservative choice overall.

Frequently Asked Questions

Q: Can I take all three together? Combining Sermorelin + Ipamorelin or CJC-1295 + Ipamorelin makes sense. Combining CJC-1295 + Sermorelin (two GHRH analogs) adds little because they act on the same receptor — you would not gain meaningfully from stacking two GHRH analogs.

Q: Do I need a prescription for these peptides? Sermorelin is available through compounding pharmacies with a prescription. Ipamorelin and CJC-1295 are sold as research peptides in the US. Regulatory status varies by country.

Q: How long until I notice results? Most people notice improved sleep quality within 1–2 weeks. Body composition changes typically emerge after 6–12 weeks of consistent use.

Q: What is the difference between CJC-1295 with DAC and without DAC? DAC (Drug Affinity Complex) extends half-life from 30 minutes to 6–8 days, creating continuous GH elevation rather than pulsatile release. Most protocols now prefer the without-DAC version for more physiologic pulsatility.

Q: Which should I use if I can only afford one? If monotherapy: Sermorelin is the most clinically validated single agent. If you want effectiveness, the CJC-1295 + Ipamorelin combination is worth the modest additional cost over Sermorelin alone.